Hana Must SPAC 2 - Asset Resilience Ratio
Hana Must SPAC 2 (208370) has an Asset Resilience Ratio of 18.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Hana Must SPAC 2 debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Hana Must SPAC 2's Asset Resilience Ratio has changed over time. See what is Hana Must SPAC 2's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Hana Must SPAC 2's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 208370 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩12.80 Billion | 18.07% |
| Total Liquid Assets | ₩12.80 Billion | 18.07% |
Asset Resilience Insights
- Good Liquidity Position: Hana Must SPAC 2 maintains a healthy 18.07% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hana Must SPAC 2 Industry Peers by Asset Resilience Ratio
Compare Hana Must SPAC 2's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Hana Must SPAC 2 (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Hana Must SPAC 2.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 37.15% | ₩26.09 Billion ≈ $17.68 Million |
₩70.22 Billion ≈ $47.59 Million |
+0.74pp |
| 2023-12-31 | 36.41% | ₩24.28 Billion ≈ $16.45 Million |
₩66.68 Billion ≈ $45.19 Million |
+20.76pp |
| 2022-12-31 | 15.65% | ₩7.06 Billion ≈ $4.79 Million |
₩45.11 Billion ≈ $30.57 Million |
-14.71pp |
| 2021-12-31 | 30.36% | ₩14.87 Billion ≈ $10.08 Million |
₩48.98 Billion ≈ $33.20 Million |
+0.14pp |
| 2020-12-31 | 30.22% | ₩13.64 Billion ≈ $9.24 Million |
₩45.14 Billion ≈ $30.59 Million |
+2.75pp |
| 2019-12-31 | 27.48% | ₩12.94 Billion ≈ $8.77 Million |
₩47.11 Billion ≈ $31.92 Million |
+24.01pp |
| 2018-12-31 | 3.46% | ₩1.43 Billion ≈ $968.25K |
₩41.26 Billion ≈ $27.96 Million |
-2.55pp |
| 2017-12-31 | 6.01% | ₩3.29 Billion ≈ $2.23 Million |
₩54.70 Billion ≈ $37.07 Million |
-4.36pp |
| 2016-12-31 | 10.37% | ₩4.71 Billion ≈ $3.20 Million |
₩45.48 Billion ≈ $30.82 Million |
+10.33pp |
| 2015-12-31 | 0.03% | ₩16.50 Million ≈ $11.18K |
₩47.25 Billion ≈ $32.02 Million |
-- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more